Building a Regenerative Treatment Plan Around Polynucleotides

As patients increasingly ask for natural, lasting results rather than an obvious “done” look, regenerative aesthetics has moved from novelty to foundation. Polynucleotides sit at the heart of that shift — and building a treatment plan around them, rather than treating them as a one-off add-on, is how clinicians deliver the skin-quality results patients now want. Think of them less as a single treatment and more as the base layer of a longer-term strategy.
Start with the skin, not the symptom
A regenerative approach begins by treating the health and quality of the skin before, or alongside, addressing lines and volume. Polynucleotides improve hydration, elasticity and dermal quality by supporting the skin’s own repair, creating a better foundation on which any other treatment performs. Preparing the canvas first often means less filler and toxin are needed later, and the overall result looks more natural.
Think in courses and maintenance
Regenerative results are cumulative. Polynucleotides are typically delivered as an initial course of sessions spaced a couple of weeks apart, followed by periodic maintenance to sustain the improvement. Planning that rhythm with the patient from the outset — rather than treating reactively — sets honest expectations and builds the kind of ongoing relationship that keeps a clinic healthy.
Layer with other modalities thoughtfully
Polynucleotides do not replace fillers or toxins; they complement them. A considered plan might prepare and improve the skin with a course of polynucleotides, address dynamic lines with toxin, and restore structure with filler where genuinely needed — each doing what it does best, sequenced sensibly. The result is a comprehensive, natural improvement that no single treatment could achieve alone.
Match the plan to the patient
Regenerative planning is inherently individual. A younger patient may use polynucleotides largely preventively, to maintain skin quality; an older patient may combine them with more structural work. Assess the whole face and the patient’s goals, and design a plan that evolves with them over time rather than a fixed package applied to everyone.
Position it clearly on your menu
Because regenerative treatment sells on outcomes over time, it lends itself to courses and maintenance plans rather than single sessions. Presenting polynucleotides as the foundation of a skin-quality pathway — with a clear course and a maintenance rhythm — helps patients commit and gives your clinic predictable, recurring revenue.
Communicate the long game
The biggest shift for many patients is understanding that regenerative treatment is a journey, not an event. Explaining that results build gradually, that maintenance sustains them, and that the goal is healthy, resilient skin over time is what turns a curious patient into a committed one. Patients who understand the plan stay on it — and get better results because they do.
Built into a considered, long-term plan, polynucleotides become far more than a trend treatment: they are the regenerative foundation on which natural, lasting results — and loyal, well-looked-after patients — are built.
References
- Squadrito F, et al. Pharmacological Activity and Clinical Use of PDRN. Frontiers in Pharmacology. 2017;8:224.
- Lampridou, et al. The Effectiveness of Polynucleotides in Esthetic Medicine: A Systematic Review. Journal of Cosmetic Dermatology. 2025.
- A literature review on polynucleotide efficacy on skin rejuvenation, and the regulatory status and guidelines around polynucleotides. Journal of Aesthetic Nursing.


